These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancer. Boven E; Schlüper HM; Erkelens CA; Pinedo HM Eur J Cancer; 1990; 26(9):983-6. PubMed ID: 2149026 [TBL] [Abstract][Full Text] [Related]
8. Anthracycline analogs: the past, present, and future. Weiss RB; Sarosy G; Clagett-Carr K; Russo M; Leyland-Jones B Cancer Chemother Pharmacol; 1986; 18(3):185-97. PubMed ID: 2948729 [No Abstract] [Full Text] [Related]
9. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds. Wadler S; Fuks JZ; Wiernik PH J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917 [TBL] [Abstract][Full Text] [Related]
10. [Current status of clinical results of new antitumor drugs]. Ogawa M Gan To Kagaku Ryoho; 1985 Feb; 12(2):179-88. PubMed ID: 3918502 [TBL] [Abstract][Full Text] [Related]
11. The biochemical pharmacology of nogalamycin and its derivatives. Li LH; Krueger WC Pharmacol Ther; 1991; 51(2):239-55. PubMed ID: 1838416 [TBL] [Abstract][Full Text] [Related]
12. Phase I study of oral menogaril administered daily for 14 consecutive days. Stewart DJ; Aitken SE; Verma S; Maroun JA; Robillard L; Touchie M; Prosser IA; Earhart R Ann Oncol; 1992 May; 3(5):401-3. PubMed ID: 1535508 [TBL] [Abstract][Full Text] [Related]
13. Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study. Brown TD; Goodman PJ; Fleming TR; Baker LH; Macdonald JS Invest New Drugs; 1991 Feb; 9(1):77-8. PubMed ID: 1827433 [No Abstract] [Full Text] [Related]
14. Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial. Gundersen S; Monfardini S; Renard G; Van Glabbeke M; Pinedo H Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1707-8. PubMed ID: 2962875 [No Abstract] [Full Text] [Related]
15. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial. Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053 [No Abstract] [Full Text] [Related]
16. Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung. Joss RA; Monfardini S; Hansen M; Dombernowsky P; Renard J; Pinedo HM Eur J Cancer Clin Oncol; 1988 Feb; 24(2):263-5. PubMed ID: 2833403 [No Abstract] [Full Text] [Related]
17. The development of new chemotherapeutic agents. Hanauske AR Anticancer Drugs; 1996 Aug; 7 Suppl 2():29-32. PubMed ID: 8862708 [TBL] [Abstract][Full Text] [Related]
18. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives. Young CW; Raymond V Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251 [No Abstract] [Full Text] [Related]
19. Phase II evaluation of menogaril in patients with advanced hypernephroma. Long HJ; Hauge MD; Therneau TM; Buckner JC; Frytak S; Hahn RG Invest New Drugs; 1991 Aug; 9(3):261-2. PubMed ID: 1838363 [TBL] [Abstract][Full Text] [Related]
20. Menogaril in the treatment of malignant mesothelioma: a phase II study. Hudis CA; Kelsen DP Invest New Drugs; 1992 Jul; 10(2):103-6. PubMed ID: 1386842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]